Predicting drug loading in PLA-PEG nanoparticles

被引:44
|
作者
Meunier, M. [1 ]
Goupil, A. [2 ]
Lienard, P. [3 ]
机构
[1] Dassault Syst Biovia, 334 Milton Rd Sci Pk, Cambridge CB4 0WN, England
[2] Dassault Syst Biovia, 10 Rue Marcel Dassault, F-78140 Velizy Villacoublay, France
[3] Sanofi R&D, Pharmaceut Sci Dev, 13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France
基金
欧盟地平线“2020”;
关键词
Drug delivery; Nanoparticles; Nanomedicine; Drug loading; Pharmaceutical development; Molecular dynamics; Solvation free energy; SOLUBILITY PARAMETERS; POLYMER MISCIBILITY; FORCE-FIELD; COEFFICIENTS; SIMULATION; MOLECULES; MIXTURES; DELIVERY;
D O I
10.1016/j.ijpharm.2017.04.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymer nanoparticles present advantageous physical and biopharmaceutical properties as drug delivery systems compared to conventional liquid formulations. Active pharmaceutical ingredients (APIs) are often hydrophobic, thus not soluble in conventional liquid delivery. Encapsulating the drugs in polymer nanoparticles can improve their pharmacological and bio-distribution properties, preventing rapid clearance from the bloodstream. Such nanoparticles are commonly made of non-toxic amphiphilic self assembling block copolymers where the core (poly-[D,L-lactic acid] or PLA) serves as a reservoir for the API and the external part (Poly-(Ethylene-Glycol) or PEG) serves as a stealth corona to avoid capture by macrophage. The present study aims to predict the drug affinity for PLA-PEG nanoparticles and their effective drug loading using in silico tools in order to virtually screen potential drugs for non-covalent encapsulation applications. To that end, different simulation methods such as molecular dynamics and Monte-Carlo have been used to estimate the binding of actives on model polymer surfaces. Initially, the methods and models are validated against a series of pigments molecules for which experimental data exist. The drug affinity for the core of the nanoparticles is estimated using a Monte-Carlo "docking" method. Drug miscibility in the polymer matrix, using the Hildebrand solubility parameter (delta), and the solvation free energy of the drug in the PLA polymer model is then estimated. Finally, existing published ALogP quantitative structure-property relationships (QSPR) are compared to this method. Our results demonstrate that adsorption energies modelled by docking atomistic simulations on PLA surfaces correlate well with experimental drug loadings, whereas simpler approaches based on Hildebrand solubility parameters and Flory-Huggins interaction parameters do not. More complex molecular dynamics techniques which use estimation of the solvation free energies both in PLA and in water led to satisfactory predictive models. In addition, experimental drug loadings and Log P are found to correlate well. This work can be used to improve the understanding of drug-polymer interactions, a key component to designing better delivery systems. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 50 条
  • [41] Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent
    Chen, Zhijin
    Yu, Dexin
    Liu, Chunxi
    Yang, Xiaoyan
    Zhang, Na
    Ma, Chunhong
    Song, Jibin
    Lu, Zaijun
    JOURNAL OF DRUG TARGETING, 2011, 19 (08) : 657 - 665
  • [42] pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma
    Householder, Kyle T.
    DiPerna, Danielle M.
    Chung, Eugene P.
    Luning, Anne Rosa
    Nguyen, Duong T.
    Stabenfeldt, Sarah E.
    Mehta, Shwetal
    Sirianni, Rachael W.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 166 : 37 - 44
  • [43] Characterizations of PLA-PEG blends involving organically modified montmorillonite
    Ozdemir, Esra
    Hacaloglu, Jale
    JOURNAL OF ANALYTICAL AND APPLIED PYROLYSIS, 2017, 127 : 343 - 349
  • [44] Preparation of biodegradable PLA-PEG copolymer microspheres with micron sizes
    Gaofenzi Cailiao Kexue Yu Gongcheng, 3 (20-22):
  • [45] Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir
    Gourdon, Betty
    Chemin, Caroline
    Moreau, Amelie
    Arnauld, Thomas
    Baumy, Philippe
    Cisternino, Salvatore
    Pean, Jean-Manuel
    Decleves, Xavier
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 529 (1-2) : 357 - 370
  • [46] Folate conjugated luminescent difluoroboron β-diketonate PLA-PEG stereocomplex nanoparticles for multicolor and tumor oxygen imaging
    Zhuang, Meng
    Rickard, Ashlyn
    DeRosa, Christopher
    Palmer, Gregory
    Fraser, Cassandra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [47] Evaluation of In Vivo toxicity of Novel Biosurfactant from Candida parapsilosis loaded in PLA-PEG Polymeric Nanoparticles
    Rana, Samriti
    Singh, Joga
    Wadhawan, Aishani
    Khanna, Archna
    Singh, Gurpal
    Chatterjee, Mary
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (04) : 1727 - 1738
  • [48] Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres
    Ren, Jie
    Yu, Xiao
    Ren, Tianbin
    Hong, Haiyan
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2007, 18 (08) : 1481 - 1487
  • [49] Harnessing the power of PLA-PEG nanoparticles for Linezolid delivery against methicillin-resistant Staphylococcus aureus
    Oliva, Roberto
    Ginestra, Giovanna
    Piperno, Anna
    Mazzaglia, Antonino
    Nostro, Antonia
    Scala, Angela
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 642
  • [50] Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles
    Riley, T
    Stolnik, S
    Heald, CR
    Xiong, CD
    Garnett, MC
    Illum, L
    Davis, SS
    Purkiss, SC
    Barlow, RJ
    Gellert, PR
    LANGMUIR, 2001, 17 (11) : 3168 - 3174